Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
The Nashua Telegraph· 6 days agoSIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents...
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request
Dayton Daily News· 7 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 2 days agoNovavax retains its pipeline rights and could earn substantial royalties from Sanofi's development...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 10 hours agoThe drug maker experienced a massive surge in sales and earnings during the COVID-19 pandemic's...
WHO in talks to finalize ‘pandemic treaty’ | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 3 days agoAfter the coronavirus pandemic triggered once-unthinkable lockdowns, upended economies and killed...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Pandemic talks extended as deadline passes
Medical Xpress· 4 days agoScarred by the devastation caused by COVID-19—which killed millions, shredded economies and crippled health systems—the World Health Organization's 194...
Why aren’t we vaccinating birds against bird flu?
Vox· 13 hours agoH5N1 — the strain of highly pathogenic avian influenza circulating — currently poses little threat to people as spillover from animals to humans is rare,...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 5 days agoThe partnership with Sanofi allows Novavax Inc (NVAX) to leverage Sanofi's extensive global vaccine business expertise, potentially leading to hundreds of millions of dollars ...